Literature DB >> 1851766

Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons.

M Vrethem1, T Skogh, G Berlin, H Holmgren, J Ernerudh.   

Abstract

To study the role of autoantibodies against peripheral nerve myelin (PNM), sera from 255 healthy blood donors were investigated by enzyme-linked immunosorbent assay (ELISA), and persons with anti-PNM antibodies were further studied clinically and by neurography, 25 blood donors (10%) had anti-PNM antibodies of IgM, IgG or IgA isotype. The 12 blood donors with anti-PNM antibodies of IgM isotype showed only slightly decreased nerve conduction velocities compared to 12 blood donors without anti-PNM antibodies. Two blood donors with anti-PNM antibodies of IgM and IgG isotype respectively showed a clinical, previously undiagnosed polyneuropathy (PN), verified by neurography. However, also one blood donor without anti-PNM antibodies had a clinical and neurography-verified PN. We conclude that antibodies against PNM may occur in healthy persons without evidence of a clinical or subclinical PN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851766     DOI: 10.1016/0165-5728(91)90191-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.

Authors:  C Ekerfelt; J Ernerudh; G Solders; M Vrethem
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

Authors:  M Vrethem; T Skogh; J Ernerudh; B Ekstedt; O Andersen; J Lycke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

3.  Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).

Authors:  M Kvarnstrom; E Sidorova; J Nilsson; C Ekerfelt; M Vrethem; O Soderberg; M Johansson; A Rosen; J Ernerudh
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

4.  Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy.

Authors:  J H Ernerudh; M Vrethem; O Andersen; C Lindberg; G Berlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

5.  Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; B Mark Keegan; Jeffrey L Winters; David Astapenko; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  Neurol Res Int       Date:  2011-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.